ZNTL · Forms 3, 4, 5
Insider trades at Zentalis Pharmaceuticals, Inc.
1 insider bought $15.2M of Zentalis Pharmaceuticals, Inc. stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for Zentalis Pharmaceuticals, Inc. (ZNTL) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Ingmar Bruns | Chief Medical Officer | Award | 9,727 | $2.18 | $21K | Form 4 | |
| WALTERS GROUP | 10% owner | Buy | 4,335,000 | $3.50 | $15.2M | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.